Verastem (VSTM) Non-cash Items (2011 - 2026)
Verastem (VSTM) recorded quarterly Non-cash Items of $855000.0 in Q1 2026, down 68.69% quarter-over-quarter from $2.7 million in Q4 2025, and down 28.27% on a YoY basis from $1.2 million in Q1 2025.
Verastem (VSTM) Non-cash Items (2011 - 2026) Analysis & Trends
Verastem's Non-cash Items history runs 16 years deep, the most recent figure standing at $855000.0 for Q1 2026.
- In Q1 2026, Non-cash Items fell 28.27% year-over-year to $855000.0; the TTM figure through Mar 2026 stood at $855000.0 (down 28.27% YoY), while the FY2025 annual figure was $2.7 million, up 223.96% from the prior year.
- Non-cash Items was $855000.0 for Q1 2026 at Verastem, down from $2.7 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $4.7 million in Q3 2025 to a low of $18000.0 in Q4 2022.
- Historically, Non-cash Items has averaged $1.1 million across 5 years, with a median of $470000.0 in 2023.
- The sharpest annual moves came in 2022 and 2025: Non-cash Items plunged 99.9% in 2022, then soared 26250.0% in 2025.
- A 5-year view of Non-cash Items shows it stood at $18000.0 in 2022, then surged by 3005.56% to $559000.0 in 2023, then surged by 50.81% to $843000.0 in 2024, then surged by 223.96% to $2.7 million in 2025, then sank by 68.69% to $855000.0 in 2026.
- The last three Non-cash Items figures came in at $855000.0 (Q1 2026), $2.7 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 855,000.00 |
| Mar 31, 2026 | 855,000.00 |
| Dec 31, 2025 | 2.73 Mn |
| Dec 31, 2025 | 2.73 Mn |
| Sep 30, 2025 | 4.74 Mn |
| Sep 30, 2025 | 4.74 Mn |
| Jun 30, 2025 | 397,000.00 |
| Jun 30, 2025 | 397,000.00 |
| Mar 31, 2025 | 1.19 Mn |
| Mar 31, 2025 | 1.19 Mn |
| Dec 31, 2024 | 843,000.00 |
| Dec 31, 2024 | 843,000.00 |
| Sep 30, 2024 | 18,000.00 |
| Sep 30, 2024 | 18,000.00 |
| Mar 31, 2024 | 4.54 Mn |
| Mar 31, 2024 | 4.54 Mn |
| Dec 31, 2023 | 559,000.00 |
| Dec 31, 2023 | 559,000.00 |
| Sep 30, 2023 | 470,000.00 |
| Sep 30, 2023 | 470,000.00 |